Pöördumine

Saatja: Webdesktop <[email protected]> Saadetud: 29.06.2022 12:50 Adressaat: SM Info <[email protected]>; <[email protected]>; Elen Ohov <[email protected]> Koopia: <[email protected]>; <[email protected]>; <[email protected]>; <[email protected]> Teema: Webdesktop: Kiri nr 14-4/677 / Kandideerimiskutse ekspertrühma - AMR (antimicrobial resistance) One Health Network Tere!Edastan Komisjoni kirja.Reg. number: 14-4/677Reg. kuupäev: 29.06.2022Sisu: Call for applications for the selection of members of the expert group Antimicrobial Resistance (AMR) One Health NetworkHeade soovidegaTiiu [email protected]är, EV alaline esindus EL juures Saatja: [email protected] <[email protected]> Saaja: AT Viktor Szontagh, BE Marie Baerts, BG Georgi Agov, BG ESKIDAROVA Zefira, BG FMB, BG Ginova Antoaneta, CY Yiola IACOVOU, CZ NEMEC Stanislav, CZ Richard Wallo, DE Alper Tasdelen, DK FMB, DK Louise Juul Ledstrup, Reili Kivilo, ES Miguel Angel Martin Esteban, FI FMB, FI Horman Ari, FR Claire Morlot, FR Herbreteau Rachel, FR Poncon Nicolas, FR Fabien Schneegans, GR Angeliki Ioannou Kapota, GR Vasileios Xanthopoulos, HR Danijela Lamer, HR Zoran Rogic, HU Gabor Wyszoczky, IE O'DONNELL Donal, IT FMB, IT GUIZZARDI Sarah, LT Darius Remeika, LU Marc Kreis, LV Liene.Ansone, MT DALLI James, NL Ata Vahdatzade, PL Aleksandra Falat, PL Sebastian Zwan, PT Henrique Sales Henriques, RO Adrian Ardelean, RO Ana Maria Popa, SE Jerker Stattin, SI Marko Potocnik, SK Janiuk Lubomir, AT - Permanent Representation, BE - Permanent Representation, BG - Permanent Representation, CY - Permanent Representation, CZ - Permanent Representation, DE - Permanent Representation, DK - Permanent Representation, Esindus EL juures üldaadress, EL - Permanent Representation, ES - Permanent Representation, FI - Permanent Representation, FR - Permanent Representation, HR - Permanent Representation, HU - Permanent Representation, IE - Permanent Representation, IT - Permanent Representation, LT - Permanent Representation, LU - Permanent Representation, LV - Permanent Representation, MT - Permanent Representation, NL - Permanent Representation, PL - Permanent Representation, PT - Permanent Representation, RO - Permanent Representation, SE - Permanent Representation, SI - Permanent Representation, SK - Permanent Representation, [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], Agne Nettan-Sepp, [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], CVO AT Herzog Ulrich, CVO BE (deputy) Claeys Herman, CVO BE FMB, CVO BE Heymans Jean-François, CVO BG FMB, CVO BG Hristo Daskalov, CVO CY Hristodoulos Pipis, CVO CY Pipis Christodouloss, CVO CZ FMB, CVO CZ Zbynek Semerád, CVO DE RASSOW Dietrich, CVO DK Charlotte VILSTRUP, CVO DK FMB, CVO EE FMB, CVO EE Hele-Mai Sammel, CVO ES Almansa Valentin, CVO FI Aaltonen Taina, CVO FI FMB, CVO FR Emmanuelle Soubeyran, CVO GR Alexandropoulos Thomas, CVO GR Alexandropoulos Thomas 2, CVO HR FMB, CVO HR Tatjana KARACIC, CVO HU FMB, CVO HU Lajos Bognar, CVO IE FMB, CVO IE Martin Blake, CVO IT FMB, CVO IT FMB 2, CVO IT Pierdavide LECCHINI, CVO LT FMB, CVO LT Mantas Staškevicius, CVO LU Wildschutz Felix, CVO LV Balodis Maris, CVO LV FMB, CVO MT FMB, CVO MT Paul Joseph Portelli, CVO NL Wim Pelgrim, CVO NL FMB, CVO PL (deputy) Krzysztof JAZDZEWSKI, CVO PL (deputy) Pawel Meyer, CVO PL FMB, CVO PL Pawel Niemczuk, CVO PT FMB, CVO PT Susana GUEDES POMBO, CVO RO Alexandru Nicolae BOCIU, CVO SE Lena Bjornerot, CVO SE FMB, CVO SI FMB, CVO SI Matjaž Gucek, CVO SK Bires Jozef, CVO SK FMB, CVO CH FMB, CVO CH Wyss Hans, CVO IS (acting) Audur Lilja Arnthorsdottir, CVO IS Daðadóttir Sigurbjörg, CVO IS FMB, CVO NO FMB, CVO NO Knut Rønningen, CH Peter Braam, IS FMB, IS Fridriksson Ólafur, NO mission, NO Mission Stein Ivar Ormsettrø, [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], Margus Korsjukov (KeM), [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected] Teema: Ares(2022)4709385 - Call for applications for the selection of members of the expert group ‘Antimicrobial Resistance (AMR) One Health Network’ Dear Colleagues, Please find attached a letter on the above-mentioned subject. No paper copy will follow. Kind regards, The AMR One Health Network team [cid:[email protected]] European Commission DG Health and Food Safety Unit G5 - Animal welfare, Antimicrobial resistance [email protected]<mailto:[email protected]> Ref. Ares(2022)4709385 - 28/06/2022 EUROPEAN COMMISSION Directorate-General Health and Food Safety (DG SANTE) Directorate G Crisis preparedness in food, animals and plants INFORMAL COMMISSION EXPERT GROUP: ANTIMICROBIAL RESISTANCE (AMR) ONE HEALTH NETWORK TERMS OF REFERENCE 1. BACKGROUND The Antimicrobial Resitance (AMR) One Health Network was set up in 2017 as an ad-hoc group to follow-up the developments of the 2017 EU AMR Action Plan1, and enhance the coordination and dialogue between the human health, veterinary and environmental sectors in the EU institutions and in Member States. The group holds biannual meetings. Addressing AMR through a One Health approach continues to be a priority of the Commission. Additionaly, there is a need to discuss AMR related topics going beyond 2017 EU AMR Action Plan. This requires that the existing One Health Network2 is set up or formalised as a Commission expert group where AMR related information is shared across the three sectors, for example as regards: - analysing the AMR situations in all Member States and trends over time and providing recommendations on requested topics; - exchanging and identyfing best practices to set up AMR One Health National Action Plans; - exchanging on relevant policy developments, e.g. AMR aspects of the revision of the EU serious cross-border health threats legislation, of the EU Pharmaceutical Strategy, of the new Health Emergency Preparedness and Response Authority (HERA), or of the new EU Regulations on veterinary medicinal products and medicated feed; - sharing information with Member States on funding opportunities to support efforts on AMR, including through the EU4Health programme and the EU structural funds; - sharing information on relevant research and scientific developments; - coordinating the EU strategy to promote actions to tackle AMR at global level. 1 https://ec.europa.eu/health/sites/default/files/antimicrobial_resistance/docs/amr_2017_action-plan.pdf 2 The AMR One Health Network was created as an ad-hoc group to follow up 2017 EU AMR One Health Action Plan. 0 2. TASKS The AMR One Health Network’s tasks shall be: (a) to assist DG Health and Food Safety (DG SANTE) and associated DGs (in particular DG RTD, DG AGRI, DG REFORM, DG MARE, DG ENV, DG TRADE, HERA, JRC) in identyfing the needs for policy initiatives in the field of AMR One Health and providing input for their development; (b) to support coordination between the Commission services and Member States as well as stakeholders on questions relating to the implementation of Union legislation, programmes and policies in the field of AMR in the context of the One Health approach; (c) to exchange experience and identify best practices in the field of AMR in the context of the One Health approach; (d) to foster a common understanding and promote an implementation in practice of the concept of the One Health approach in the case of the fight against AMR; (e) to work towards facilitating mutual learning, sharing innovative ideas, building consensus, comparing progress made in key areas and, where necessary, accelerating national efforts to tackle AMR. 3. CONSULTATION DG SANTE may consult the AMR One Health Network on any matter relating to antimicrobial resistance in the context of the AMR One Health approach. 4. MEMBERSHIP 1. The AMR One Health Network shall be composed of not more than 82 members. 2. Members shall be: a) Member States' authorities representing ministries responsible for public health, food safety, veterinary matters, plant health and environment (at least 3 representatives per Member State covering the 3 sectors – public health, veterinary/food safety/plant health, environment); as well as of those non-EU countries which are contracting parties to the Agreement on the European Economic Area; b) EU level professional organisations and organisations of the civil society (20 professional organisations and 15 civil society organisations); c) public entities such as EU agencies (up to 5 agencies), EU Reference Laboratories (up to 2 Laboratories) and international organisations (up to 5 international organisations), which have an interest in following discussions relating to AMR in the context of One Health dimension; d) independent experts from academic and research institutes (up to 5 independent experts). 3. Members listed under paragraph 2(d) are appointed in a personal capacity and shall act independently and in the public interest. 4. Members listed in paragraphs 2(b), 2(c) and 2(d) may participate only for the agenda items which are open to all members. In each meeting, some agenda items may be restricted to members listed in paragraph 2(a) only. 1  5. Members listed under paragraphs 2(a) and 2(c) shall nominate their representatives and shall be responsible for ensuring that their representatives provide a high level of expertise. 6. Members listed under paragraphs 2(b) and 2(d) shall be selected according to the procedure laid down in Article 5. Members listed under paragraph 2(b) shall nominate their representatives (one representative per member) in the AMR One Health Network at senior-level and shall be responsible for ensuring that their representatives are permanent and provide a sufficiently high level of expertise. DG SANTE may refuse a representative nominated by these members if it considers this nomination inappropriate in the light of the requirements specified in the call for applications. 7. Members who are no longer capable of contributing effectively to the expert group’s deliberations, who, in the opinion of DG SANTE, do not comply with the conditions set out in Article 339 of the Treaty on the Functioning of the European Union or who resign, shall no longer be invited to participate in any meetings of the group and may be replaced for the remainder of their term of office. 5. SELECTION PROCESS 1. Public entities shall be appointed by direct invitation. 2. The selection of the group’s members under paragraphs 4(2)(b) and 4(2)(d) shall be carried out via a public call for applications, to be published on the Register of Commission expert groups and other similar entities (‘the Register of expert groups’). In addition, the call for applications may be published through other means, including on the European Commission’s webpages. The call for applications shall clearly outline the selection criteria, including the required expertise and the interests to be represented in relation to the work to be performed. The minimum deadline for applications shall be four weeks. 3. Members listed under Article 4(2)(d) applying to be appointed as members of the group in a personal capacity shall disclose any circumstances that could give rise to a conflict of interest. In particular, the Commission shall require those individuals to submit a declaration of interests (‘DOI’) form on the basis of the standard DOI form for expert groups3, together with an updated curriculum vitae (CV), as part of their application. Submission of a duly completed DOI form shall be necessary in order to be eligible to be appointed as a member in a personal capacity. The conflict of interest assessment shall be performed in compliance with the Commission’s horizontal rules on expert groups (‘the horizontal rules’)4. 4. Registration in the Transparency Register is required in order for organisations to be appointed. 5. The members of the group shall be appointed by the the Director-General of DG SANTE from applicants with competence in the areas referred to in point 3 and who have responded to the call for applications. 3 C(2016), Article 11 and Annex 4. 4 Idem. 2  6. Members shall be appointed for 5 years. They shall remain in office until the end of their term of office. Their term of office may be renewed. 7. DG SANTE shall establish a reserve list of suitable candidates that may be used to appoint members’ replacements. DG SANTE shall ask applicants for their consent before including their names on the reserve list. 6. CHAIR The group shall be chaired by a representative of DG SANTE. 7. OPERATION 1. The group shall act at the request of DG SANTE, in compliance with the horizontal rules5. 2. Meetings of the group shall in principle be held on Commission premises or virtually, depending on the circumstances. 3. DG SANTE shall provide secretarial services. Commission officials from other departments with an interest in the disussions may attend meetings of the group and its sub-groups. 4. In agreement with DG SANTE, the group may, by simple majority of its members, decide that deliberations shall be public. 5. Minutes on the discussion on each point on the agenda and on the opinions delivered by the group shall be meaningful and complete and shall be published. Minutes shall be drafted by the secretariat under the responsibility of the Chair. 6. As far as possible, the group shall provide its opinions, recommendations or reports by consensus. 8. SUB-GROUPS 1. The network may set up sub-groups for the purpose of examining specific questions on the basis of terms of reference defined by DG SANTE. Sub-groups shall operate in compliance with the horizontal rules set in the Commission Decision C(2016)3301 and shall report to the group. They shall be dissolved as soon as their mandate is fulfilled. 2. The members of sub-groups that are not members of the group of the type listed under paragraphs 2(b) and 2(d) shall be selected via a public call for applications, in compliance with point 6 and the horizontal rules6. 9. INVITED EXPERTS DG SANTE may invite experts with specific expertise with respect to a subject matter on the agenda to take part in the work of the group or sub-groups on an ad hoc basis. 5 C(2016) 3301, Article 13.1. 6 C(2016), Articles 10 and 14.2. 3 10. OBSERVERS 1. Individuals, organisations and public entities other than Member States’ authorities may be granted an observer status, in compliance with the horizontal rules, by direct invitation. 2. Organisations and public entities appointed as observers shall nominate their representatives. 3. Observers and their representatives may be permitted by the Chair to take part in the discussions of the group and sub-groups and provide expertise. However, they shall not participate in the formulation of recommendations or advice of the group and sub-groups. 4. The group shall not have more than 5 observers. 11. RULES OF PROCEDURE On a proposal by and in agreement with DG SANTE, the group shall adopt its rules of procedure by simple majority of its members, on the basis of the standard rules of procedure for expert groups, in compliance with the horizontal rules7. Sub-groups shall operate in compliance with the group’s rules of procedure. 12. PROFESSIONAL SECRECY AND HANDLING OF CLASSIFIED INFORMATION The members of the group and their representatives, as well as invited experts and observers, are subject to the obligation of professional secrecy, which by virtue of the Treaties and the rules implementing them applies to all members of the institutions and their staff, as well as to the Commission's rules on security regarding the protection of Union classified information, laid down in Commission Decisions (EU, Euratom) 2015/4438 and 2015/4449. Should they fail to respect these obligations, the Commission may take all appropriate measures. 13. TRANSPARENCY 1. The group and sub-groups shall be registered in the Register of expert groups. 2. As regards the group and sub-groups composition, the following data shall be published on the Register of expert groups: a) the names of individuals appointed in a personal capacity; b) the name of member states’ authorities and EEA countries; c) the name of other public entities who are members of the group; d) the name of member organisations; the interest shall be disclosed; e) the name of observers. 7 See Article 17 of the horizontal rules. 8 Commission Decision (EU, Euratom) 2015/443 of 13 March 2015 on Security in the Commission (OJ L 72, 17.3.2015, p. 41). 9 Commission Decision (EU, Euratom) 2015/444 of 13 March 2015 on the security rules for protecting EU classified information (OJ L 72, 17.3.2015, p. 53). 4 3. All relevant documents, including the agendas, the minutes and the participants’ submissions shall be made available via a link from the Register to the dedicated European Commission webpage, where this information can be found. Access to the European Commission webpage displaying these documents shall not be submitted to user registration or any other restriction. In particular, DG SANTE shall publish the agenda and other relevant background documents in due time ahead of the meeting, followed by timely publication of minutes. Exceptions to publication shall only be possible where it is deemed that disclosure of a document would undermine the protection of a public or private interest as defined in Article 4 of Regulation (EC) N° 1049/2001. 14. MEETING EXPENSES 1. Participants in the activities of the group and sub-groups shall not be remunerated for the services they offer. 2. Travel and subsistence expenses, including accomodation allowance, incurred by participants in the activities of the group and sub-groups shall be reimbursed by the Commission. Reimbursement shall be made in accordance with the provisions in force within the Commission and within the limits of the available appropriations allocated to the Commission departments under the annual procedure for the allocation of resources. Done in Brussels, on 1/06/2022. 5 Ref. Ares(2022)4709385 - 28/06/2022 EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Public health The Director Luxembourg SANTE.DDG2.G.5/SL/NC(2022) 4732048 Subject: Call for applications for the selection of members of the expert group ‘Antimicrobial Resistance (AMR) One Health Network’ Your Excellency, I am pleased to inform you that the Directorate General for Health and Food Safety has launched a call for applications for the selection of members of the ‘AMR One Health Network’ on the following webpage: Register of Commission expert groups and other similar entities. The Antimicrobial Resitance (AMR) One Health Network was set up in 2017 following the adoption of the EU AMR Action Plan1, to enhance the coordination and dialogue between the human health, veterinary and environmental sectors in the EU institutions and in Member States. As enhancing EU actions on AMR in a one health approach continues to be a priority, the Network will now be extended partially to stakeholders, via the above-mentioned call for application. In addition, a digital tool to support the work of the AMR One Health Network has recently been developed and is in use. The call is open for applications from business, professional and civil society organisations operating at EU-level as well as independent experts from academic and research institutes with expertise in antimicrobial resistance in the context of the One Health approach. EU Member States representatives do not need to respond to the call for application as they are already member of the AMR One Health Network. Therefore, I would be grateful if you could forward this letter, with the attached documentation, to all relevant bodies or experts in your country. 1 https://ec.europa.eu/health/sites/default/files/antimicrobial_resistance/docs/amr_2017_action-plan.pdf To: Permanent Representations of all 27 Member States Copy to: Chief Veterinary Officers, Chief Public Health Officers and Representatives of the responsible Environmental Authorities of all 27 Member States, Missions of Iceland, Norway and Switzerland Commission européenne/Europese Commissie, 1049 Bruxelles/Brussel, BELGIQUE/BELGIË - Tel. +32 22991111  Applications must be submitted to the Commission by 31 August 2022. All relevant information and application documents are available in the Register of Commission expert groups. Yours faithfully, [e-signed] John-F. RYAN Contact: [email protected] Enclosure: Terms of References 2 Electronically signed on 27/06/2022 17:33 (UTC+02) in accordance with Article 11 of Commission Decision (EU) 2021/2121